Csgalnact1 Rat 17beta-estradiol multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 EGF protein inhibits the reaction [Estradiol results in decreased expression of CSGALNACT1 mRNA] CTD PMID:24758408 Csgalnact1 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSGALNACT1 mRNA CTD PMID:32741896 Csgalnact1 Rat 17beta-estradiol decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Estradiol results in decreased expression of CSGALNACT1 mRNA CTD PMID:24758408 Csgalnact1 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSGALNACT1 mRNA CTD PMID:32741896 Csgalnact1 Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of CSGALNACT1 mRNA CTD PMID:29581250 Csgalnact1 Rat 2,2',5,5'-tetrachlorobiphenyl increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 Csgalnact1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CSGALNACT1 mRNA CTD PMID:34747641 Csgalnact1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CSGALNACT1 mRNA CTD PMID:33387578 Csgalnact1 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of CSGALNACT1 mRNA CTD PMID:28300664 Csgalnact1 Rat 4,4'-sulfonyldiphenol increases expression ISO Csgalnact1 (Mus musculus) 6480464 bisphenol S results in increased expression of CSGALNACT1 mRNA CTD PMID:30951980 Csgalnact1 Rat 4-hydroxyphenyl retinamide increases expression ISO Csgalnact1 (Mus musculus) 6480464 Fenretinide results in increased expression of CSGALNACT1 mRNA CTD PMID:28973697 Csgalnact1 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of CSGALNACT1 mRNA CTD PMID:31881176 Csgalnact1 Rat aflatoxin B1 increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CSGALNACT1 mRNA CTD PMID:21632981 Csgalnact1 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CSGALNACT1 mRNA CTD PMID:33354967 Csgalnact1 Rat aflatoxin B1 decreases methylation ISO CSGALNACT1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CSGALNACT1 intron CTD PMID:30157460 Csgalnact1 Rat aflatoxin B1 increases methylation ISO CSGALNACT1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CSGALNACT1 gene CTD PMID:27153756 Csgalnact1 Rat all-trans-retinoic acid increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Tretinoin results in increased expression of CSGALNACT1 mRNA CTD PMID:21934132 and PMID:33167477 Csgalnact1 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CSGALNACT1 mRNA CTD PMID:35163327 Csgalnact1 Rat antirheumatic drug decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CSGALNACT1 mRNA CTD PMID:24449571 Csgalnact1 Rat arsenous acid increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CSGALNACT1 mRNA CTD PMID:20458559 Csgalnact1 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of CSGALNACT1 gene CTD PMID:35440735 Csgalnact1 Rat benzo[a]pyrene decreases expression ISO Csgalnact1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CSGALNACT1 mRNA CTD PMID:21569818 Csgalnact1 Rat benzo[a]pyrene affects methylation ISO CSGALNACT1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CSGALNACT1 5' UTR and Benzo(a)pyrene affects the methylation of CSGALNACT1 promoter CTD PMID:27901495 Csgalnact1 Rat benzo[a]pyrene increases methylation ISO CSGALNACT1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CSGALNACT1 exon CTD PMID:27901495 Csgalnact1 Rat benzo[a]pyrene increases expression ISO Csgalnact1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CSGALNACT1 mRNA CTD PMID:22228805 and PMID:22610609 Csgalnact1 Rat benzo[a]pyrene decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CSGALNACT1 mRNA CTD PMID:20106945 and PMID:21632981 Csgalnact1 Rat benzo[a]pyrene increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CSGALNACT1 mRNA CTD PMID:22316170 Csgalnact1 Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CSGALNACT1 mRNA CTD PMID:21839799 Csgalnact1 Rat benzo[a]pyrene diol epoxide I affects expression ISO CSGALNACT1 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 Csgalnact1 Rat benzo[a]pyrene diol epoxide I decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Csgalnact1 Rat bis(2-ethylhexyl) phthalate increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of CSGALNACT1 mRNA CTD PMID:31163220 Csgalnact1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CSGALNACT1 mRNA CTD PMID:25181051 more ... Csgalnact1 Rat bisphenol A decreases methylation ISO CSGALNACT1 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of CSGALNACT1 gene CTD PMID:31601247 Csgalnact1 Rat bisphenol A multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CSGALNACT1 gene CTD PMID:31601247 Csgalnact1 Rat bisphenol A increases expression ISO Csgalnact1 (Mus musculus) 6480464 bisphenol A results in increased expression of CSGALNACT1 mRNA CTD PMID:30951980 and PMID:35479511 Csgalnact1 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CSGALNACT1 gene CTD PMID:28505145 Csgalnact1 Rat bisphenol A decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CSGALNACT1 mRNA CTD PMID:27685785 Csgalnact1 Rat bisphenol F increases expression ISO Csgalnact1 (Mus musculus) 6480464 bisphenol F results in increased expression of CSGALNACT1 mRNA CTD PMID:30951980 Csgalnact1 Rat butanal decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of CSGALNACT1 mRNA CTD PMID:26079696 Csgalnact1 Rat cadmium atom multiple interactions ISO Csgalnact1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSGALNACT1 mRNA CTD PMID:37325564 Csgalnact1 Rat cadmium dichloride multiple interactions ISO Csgalnact1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSGALNACT1 mRNA CTD PMID:37325564 Csgalnact1 Rat calcitriol increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Calcitriol results in increased expression of CSGALNACT1 mRNA CTD PMID:21592394 Csgalnact1 Rat calcitriol multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CSGALNACT1 mRNA CTD PMID:21592394 Csgalnact1 Rat carbamazepine affects expression ISO CSGALNACT1 (Homo sapiens) 6480464 Carbamazepine affects the expression of CSGALNACT1 mRNA CTD PMID:25979313 Csgalnact1 Rat carmustine affects response to substance ISO CSGALNACT1 (Homo sapiens) 6480464 CSGALNACT1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 Csgalnact1 Rat cisplatin multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CSGALNACT1 mRNA CTD PMID:27392435 Csgalnact1 Rat cobalt dichloride decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CSGALNACT1 mRNA CTD PMID:19376846 Csgalnact1 Rat copper(II) sulfate decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CSGALNACT1 mRNA CTD PMID:19549813 Csgalnact1 Rat cyclosporin A decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CSGALNACT1 mRNA CTD PMID:27989131 Csgalnact1 Rat cylindrospermopsin increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of CSGALNACT1 mRNA CTD PMID:24921660 Csgalnact1 Rat diarsenic trioxide increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CSGALNACT1 mRNA CTD PMID:20458559 Csgalnact1 Rat Dibutyl phosphate affects expression ISO CSGALNACT1 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of CSGALNACT1 mRNA CTD PMID:37042841 Csgalnact1 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CSGALNACT1 mRNA CTD PMID:17005392 Csgalnact1 Rat dioxygen increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of CSGALNACT1 mRNA CTD PMID:26516004 Csgalnact1 Rat diquat decreases expression ISO Csgalnact1 (Mus musculus) 6480464 Diquat results in decreased expression of CSGALNACT1 mRNA CTD PMID:36851058 Csgalnact1 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of CSGALNACT1 mRNA CTD PMID:25152437 Csgalnact1 Rat dorsomorphin multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Csgalnact1 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CSGALNACT1 mRNA CTD PMID:29391264 Csgalnact1 Rat enzalutamide decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 enzalutamide results in decreased expression of CSGALNACT1 mRNA CTD PMID:29581250 Csgalnact1 Rat ethanol affects expression ISO Csgalnact1 (Mus musculus) 6480464 Ethanol affects the expression of CSGALNACT1 mRNA CTD PMID:30319688 Csgalnact1 Rat etoposide affects response to substance ISO CSGALNACT1 (Homo sapiens) 6480464 CSGALNACT1 protein affects the susceptibility to Etoposide CTD PMID:16217747 Csgalnact1 Rat fulvestrant multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CSGALNACT1 gene CTD PMID:31601247 Csgalnact1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CSGALNACT1 mRNA CTD PMID:33387578 Csgalnact1 Rat hydrogen peroxide affects expression ISO CSGALNACT1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of CSGALNACT1 mRNA CTD PMID:20044591 Csgalnact1 Rat hydroquinone increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 hydroquinone results in increased expression of CSGALNACT1 mRNA CTD PMID:31256213 Csgalnact1 Rat lead(0) affects expression ISO CSGALNACT1 (Homo sapiens) 6480464 Lead affects the expression of CSGALNACT1 mRNA CTD PMID:28903495 Csgalnact1 Rat lipopolysaccharide multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CSGALNACT1 mRNA CTD PMID:35811015 Csgalnact1 Rat MeIQx decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 Csgalnact1 Rat niclosamide multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of CSGALNACT1 mRNA] CTD PMID:27542212 Csgalnact1 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CSGALNACT1 mRNA CTD PMID:25729387 Csgalnact1 Rat ozone multiple interactions ISO Csgalnact1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CSGALNACT1 mRNA CTD PMID:34911549 Csgalnact1 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CSGALNACT1 mRNA CTD PMID:33387578 Csgalnact1 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CSGALNACT1 mRNA CTD PMID:35163327 Csgalnact1 Rat phenylmercury acetate increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of CSGALNACT1 mRNA CTD PMID:26272509 Csgalnact1 Rat phenylmercury acetate multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSGALNACT1 mRNA CTD PMID:27188386 Csgalnact1 Rat pyrvinium multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 pyrvinium inhibits the reaction [PIK3CA protein modified form results in decreased expression of CSGALNACT1 mRNA] CTD PMID:27542212 Csgalnact1 Rat quercetin increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Quercetin results in increased expression of CSGALNACT1 mRNA CTD PMID:21632981 Csgalnact1 Rat resveratrol multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CSGALNACT1 mRNA CTD PMID:23557933 Csgalnact1 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CSGALNACT1 mRNA CTD PMID:35811015 Csgalnact1 Rat SB 431542 multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Csgalnact1 Rat silicon dioxide increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of CSGALNACT1 mRNA CTD PMID:23806026 Csgalnact1 Rat silicon dioxide decreases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of CSGALNACT1 mRNA CTD PMID:34973136 Csgalnact1 Rat sodium arsenite increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CSGALNACT1 mRNA CTD PMID:29301061 and PMID:38568856 Csgalnact1 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of CSGALNACT1 mRNA CTD PMID:19281266 Csgalnact1 Rat succimer multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT1 mRNA CTD PMID:26378955 Csgalnact1 Rat temozolomide affects response to substance ISO CSGALNACT1 (Homo sapiens) 6480464 CSGALNACT1 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Csgalnact1 Rat testosterone multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CSGALNACT1 mRNA CTD PMID:21592394 Csgalnact1 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CSGALNACT1 mRNA CTD PMID:32741896 Csgalnact1 Rat testosterone increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Testosterone results in increased expression of CSGALNACT1 mRNA CTD PMID:21592394 Csgalnact1 Rat titanium dioxide decreases methylation ISO Csgalnact1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CSGALNACT1 gene CTD PMID:35295148 Csgalnact1 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CSGALNACT1 mRNA CTD PMID:25729387 Csgalnact1 Rat trimellitic anhydride decreases expression ISO Csgalnact1 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of CSGALNACT1 mRNA CTD PMID:19042947 Csgalnact1 Rat triphenyl phosphate affects expression ISO CSGALNACT1 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CSGALNACT1 mRNA CTD PMID:37042841 Csgalnact1 Rat valproic acid decreases methylation ISO CSGALNACT1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of CSGALNACT1 gene CTD PMID:29154799 Csgalnact1 Rat valproic acid multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSGALNACT1 mRNA CTD PMID:27188386 Csgalnact1 Rat valproic acid increases expression ISO CSGALNACT1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CSGALNACT1 mRNA CTD PMID:23179753 more ... Csgalnact1 Rat zidovudine multiple interactions ISO CSGALNACT1 (Homo sapiens) 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of CSGALNACT1 mRNA CTD PMID:20370541